⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002114309

Xu Cong Claire

Reports to the SEC for 1 company · ROCKVILLE, MD

Transactions

9

Companies

1

Filings

3

CIK

0002114309

Forms 4 and 5

Insider transactions

9 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-31	NBPNovaBridge BiosciencesS Sale	EVP, Clinical Development	SSale	−3,282 sh	$0.79	−$2,592.78	304,201
2026-08-30	NBPNovaBridge BiosciencesM Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	+9,382 sh	—	—	307,483
2026-08-30	NBPNovaBridge Biosciences · Restricted Share UnitsM Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	−4,079 sh	—	—	28,558
2026-07-06	NBPNovaBridge BiosciencesS Sale	EVP, Clinical Development	SSale	−4,485 sh	$0.89	−$3,991.65	298,101
2026-07-04	NBPNovaBridge BiosciencesM Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	+12.4K sh	—	—	302,586
2026-07-04	NBPNovaBridge Biosciences · Restricted Share UnitsM Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	−5,405 sh	—	—	0
2026-06-01	NBPNovaBridge BiosciencesS Sale	EVP, Clinical Development	SSale	−3,494 sh	$3.94	−$13.8K	290,154
2026-05-30	NBPNovaBridge BiosciencesM Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	+9,382 sh	—	—	293,648
2026-05-30	NBPNovaBridge Biosciences · Restricted Share UnitsM Exercise/Conversion	EVP, Clinical Development	MExercise/Conversion	−4,079 sh	—	—	32,637

Recent filings

3

Accepted (ET)
Sep 14
Xu Cong Claire0002114309-26-000007
SEC(opens sec.gov)
Jul 74
Xu Cong Claire0002114309-26-000005
SEC(opens sec.gov)
Jun 24
Xu Cong Claire0002114309-26-000003
SEC(opens sec.gov)

Companies

1

NovaBridge BiosciencesEVP, Clinical DevelopmentNBP

Address

C/O NOVABRIDGE BIOSCIENCES 2440 RESEARCH BOULEVARD, SUITE 400

ROCKVILLE, MD, 20850